Actualités Bausch Health Companies Inc - BHC | Actions Toronto Stock Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease PR...

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND...

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to...

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY PR...

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations PR...

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations PR...

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin PR...

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations PR...

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bausch Health Companies Inc (BHC)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

BHC Actualités

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes

Bausch Health Continuing Process Toward Separating Bausch + Lomb

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit

Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE)

BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS

Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation

Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bausch Health Companies Inc (BHC) Actualités

Bausch Health Companies Inc (BHC)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

BHC Actualités

OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease

SALIX PHARMACEUTICALS RELEASES LIVER HEALTH ANNUAL TRENDS REPORT UNDERSCORING CHALLENGES IN CARING FOR GROWING CHRONIC LIVER DISEASE AND CIRRHOTIC PATIENT POPULATION

Seasonal Affective Disorder (SAD) Is Now a Recognized Diagnosis in the CMS Tabular Index, Accessible to Prescribers Oct. 1, 2022

SALIX PHARMACEUTICALS APPLAUDS IMPLEMENTATION OF K76.82 - A NEW ICD-10 CODE FOR HEPATIC ENCEPHALOPATHY

Bausch Health Announces Final Results and Expiration of Exchange Offers and Consent Solicitations

Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations

Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin

Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations

Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with Support from Approximately 23% of Outstanding Existing Senior Notes

Bausch Health Continuing Process Toward Separating Bausch + Lomb

Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit

Salix Supports CMS Announcement of First ICD-10 Code for Hepatic Encephalopathy (HE)

BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS

Bausch Health Provides Update Following Oral Order in XIFAXAN® Patent Litigation

Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application